From Land to Brand
Why Cannabis’s Next Generation Is Going Asset-Light
Last year (FY24/25), Canada’s legal cannabis industry recorded revenues of CA$5.5B, according to the latest figures from Statistics Canada.
On the face of it, for an industry less than a decade old, this seems like a healthy figure, broadly comparable to Canada’s craft beer or gambling industries and even compared to these highly taxed segments, cannabis is in a league of its own.
That same year, federal and provincial governments took CA$2.5bn in taxes from cannabis sales, meaning just under half of all the money made went straight to government coffers.
It’s little wonder that almost every major player in the world’s most advanced commercial cannabis market is now competing to get their products into Europe’s emerging (excise-free) markets.
Canadian cannabis exports totaled CA$51.6m in February 2026 alone, up 8.7% year-on-year, with Germany absorbing CA$30.4m of that, marking a 763% increase on the same month two years earlier.
Unlike many of the flagship Canadian cannabis brands now flooding European cannabis markets, Herbal Dispatch, a BC-based cannabis e-commerce and distribution platform, built a business without mega-facilities or large-scale cultivation of its own.
One Friday last month, Herbal Dispatch took delivery of 500kg of cannabis at its British Columbia facility. By midday the following Sunday, the shipment was palletized.
Two days later, it landed at its destination country in Europe.
A second consignment of 261kg collected on Monday morning had cleared the airport by Tuesday afternoon. It was, the company confirmed this week, the largest single export transaction in its history.
“We held that product for less than 48 hours,” Philip Campbell, the company’s Chief Executive, told Business of Cannabis.
“We didn’t deploy any capital into the cultivation, we didn’t carry the crop risk, but we were able to move it quickly and capture real value at the distribution end.”
Supply is commodified
Herbal Dispatch places a particular focus on small-batch craft growers, and through its own direct-to-consumer platforms and export channels, it has onboarded more than 300 licensed producers, giving it access to the full range of product types, outdoor, greenhouse, indoor craft, bulk extract, and finished goods.
Canada’s domestic industry is not only severely taxed, it is also brutally competitive, with supply of raw material vastly outweighing demand.
Campbell explained:
“The supply side of the raw materials is a commodified business. A lot of the inputs are interchangeable. The real value capture is on the manufacture and branding of these products and the distribution.”
The age of high-capex vertically integrated businesses that defined the early years of Canada’s cannabis market has passed, Campbell argues, due in equal parts to necessity and a clear failure of the model. Now is the age of specialization.
“Each one of those verticals is a business unto itself. The most successful approach is to get really good at one part of the industry and expand from that strength, rather than trying to spread yourself too thin, do a lot of things, but don’t do any one thing really, really well.
“Investors are looking for companies that are disciplined in their capital allocation. A lot of investors are jaded by those companies that raised a lot of capital when the capital markets were very frothy for the cannabis sector, and then deployed capital in things that don’t really make a lot of sense.”
The first wave of Canada’s cannabis industry demonstrated the challenges associated with rapid, capital-intensive growth. Companies founded in the years that followed were shaped by those lessons, prioritizing disciplined capital allocation, scalable operating models, and operational flexibility.
Herbal Dispatch is representative of this next generation, leveraging technology, brands, distribution, and international commercialization capabilities to drive growth without the burden of significant fixed assets.
Built lean
Herbal dispatch is a prime example of this model, and it has been battle-tested. Late last year, a strike shut down British Columbia’s provincial cannabis distribution warehouse. For many, fulfilment simply stopped.
“We sold out of everything within about four hours,” Campbell recalls. “We were running ten or twelve hours a day at that point. Then we went to sixteen hours a day and sold out in two hours. And then we went to 24 hours a day within about a week and a half.”
This reactionary scaling required no additional management, new sales directors, or an expanded finance team. The company added operational headcount, seeing warehouse staff run night shifts, and saw this additional expenditure land in cost of goods sold rather than SG&A. The margin profile did not change, but revenue grew substantially.
“By being lean, we can move quickly and make decisions fast”.
Since the start of 2026, Herbal Dispatch has completed international shipments totaling approximately 1,321 kilograms of medical cannabis to Germany, Switzerland, Portugal, and Australia, funded in part by CA$200,000 in export financing secured through Export Development Canada.
In the next three to six months, the company intends to launch branded products in Germany and the UK.
“The winners will end up being capital-efficient, brand-led, and data-driven operators,” Campbell says.
“Nobody knows who grows the hops for the world’s major beer brands. I think increasingly that is going to happen in cannabis.”
Direct-to-consumer medical revenue grew 98% year-on-year in the first quarter of 2026, from CA$383,912 to CA$761,375. With the infrastructure already in place, and the ability to scale in tandem with the ever-shifting goalposts of the evolving European market, Herbal Dispatch epitomizes the incoming generation of cannabis operators.
“A lot of consumers just want the cheapest product with the highest THC,” Campbell noted.
“That commoditization means it’s not really a cultivation industry, it’s more about consumer preferences and technology insights. The winners will end up being capital-efficient, brand-led, and data-driven operators.”
This is Third-Party content and does not reflect (or not not reflect) the views of Cannabis Confidential or CB1 Capital.







